Tentarix Biotherapeutics, LP
La Jolla, US · Founded 2020 · Delaware limited partnership · 1 known investors
Creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology.
Biotech
Founders & leadership
CF
Cory FreedlandDirector
JD
Jerel DavisDirector
SA
Srinivas AkkarajuDirector
AL
Alyssa LochbaumExecutive Officer
PK
Paul KangDirector
PG
Paul GraysonExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$35MraisedSep 2023 · 5 investors · BiotechnologyRule 506(b)
▶$35MraisedSep 2023 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul KangDirector
- Allyson TigheDirector
- Thomas F. BumolDirector
- Srinivas AkkarajuDirector
- Paul GraysonExecutive Officer, Director
- Jerel DavisDirector
- Margaret KarowExecutive Officer
- Stephen DemarestExecutive Officer
- Donald J. SantelDirector
- Offering amount
- $35M
- Amount sold
- $35M
- First sale
- Aug 2023
- Incorporated
- Limited Partnership, Delaware, 2020
- Federal exemptions
- 06b
▶$8MraisedSep 2020 · 4 investors · BiotechnologyRule 506(b)
▶$8MraisedSep 2020 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Cory FreedlandDirector
- Jerel DavisDirector
- Srinivas AkkarajuDirector
- Alyssa LochbaumExecutive Officer
- Paul KangDirector
- Paul GraysonExecutive Officer, Director
- Offering amount
- $50M
- Amount sold
- $8M
- First sale
- Jul 2020
- Incorporated
- Limited Partnership, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.